|
1
|
Baylis PH and Robertson GL: Vasopressin
function in familial cranial diabetes insipidus. Postgrad Med J.
57:36–40. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deniz F, Acar C, Saglar E, Erdem B,
Karaduman T, Yonem A, Cagiltay E, Ay SA and Mergen H:
Identification of a novel deletion in AVP-NPII gene in a patient
with central diabetes insipidus. Ann Clin Lab Sci. 45:588–592.
2015.PubMed/NCBI
|
|
3
|
Saglar E, Karaduman T, Ozcan M, Erdem B,
Oflaz O, Sahin D, Deniz F, Ay AS and Mergen H: Identification of
novel mutations in AVP-NPII gene. FEBS J. 283:1312016.
|
|
4
|
Elias PC, Elias LL, Torres N, Moreira AC,
Antunes-Rodrigues J and Castro M: Progressive decline of
vasopressin secretion in familial autosomal dominant
neurohypophyseal diabetes insipidus presenting a novel mutation in
the vasopressin-neurophysin II gene. Clin Endocrinol (Oxf).
59:511–518. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Turkkahraman D, Saglar E, Karaduman T and
Mergen H: AVP-NPII gene mutations and clinical characteristics of
the patients with autosomal dominant familial central diabetes
insipidus. Pituitary. 18:898–904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gainer H, Yamashita M, Fields RL, House SB
and Rusnak M: The magnocellular neuronal phenotype: Cell-specific
gene expression in the hypothalamo-neurohypophysial system. Prog
Brain Res. 139:1–14. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murphy D and Wells S: In vivo gene
transfer studies on the regulation and function of the vasopressin
and oxytocin genes. J Neuroendocrinol. 15:109–125. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Repaske DR, Phillips JA III, Kirby LT, Tze
WJ, D'Ercole AJ and Battey J: Molecular analysis of autosomal
dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol
Metab. 70:752–757. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ito M, Mori Y, Oiso Y and Saito H: A
single base substitution in the coding region for neurophysin II
associated with familial central diabetes insipidus. J Clin Invest.
87:725–728. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Christensen JH and Rittig S: Familial
neurohypophyseal diabetes insipidus-an update. Semin Nephrol.
26:209–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Willcutts MD, Felner E and White PC:
Autosomal recessive familial neurohypophyseal diabetes insipidus
with continued secretion of mutant weakly active vasopressin. Hum
Mol Genet. 8:1303–1307. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Trimpou P, Olsson DS, Ehn O and Ragnarsson
O: Diagnostic value of the water deprivation test in the
polyuria-polydipsia syndrome. Hormones. 16:414–422. 2017.PubMed/NCBI
|
|
13
|
Rittig S, Robertson GL, Siggaard C, Kovács
L, Gregersen N, Nyborg J and Pedersen EB: Identification of 13 new
mutations in the vasopressin-neurophysin II gene in 17 kindreds
with familial autosomal dominant neurohypophyseal diabetes
insipidus. Am J Hum Genet. 58:107–17. 1996.PubMed/NCBI
|
|
14
|
Sausville E, Carney D and Battey J: The
human vasopressin gene is linked to the oxytocin gene and is
selectively expressed in a cultured lung cancer cell line. J Biol
Chem. 260:10236–10241. 1985.PubMed/NCBI
|
|
15
|
Rao VV, Löffler C, Battey J and Hansmann
I: The human gene for oxytocin-neurophysin I (OXT) is physically
mapped to chromosome 20p13 by in situ hybridization. Cytogenet Cell
Genet. 61:271–273. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Christensen JH, Siggaard C, Corydon TJ,
Robertson GL, Gregersen N, Bolund L and Rittig S: Impaired
trafficking of mutated AVP prohormone in cells expressing rare
disease genes causing autosomal dominant familial neurohypophyseal
diabetes insipidus. Clin Endocrinol (Oxf). 60:125–136. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kobayashi H, Fujisawa I, Ikeda K, Son C,
Iwakura T, Yoshimoto A, Kasahara M, Ishihara T and Ogawa Y: A novel
heterozygous missense mutation in the vasopressin moiety is
identified in a Japanese person with neurohypophyseal diabetes
insipidus. J Endocrinol Invest. 29:252–256. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian D, Cen J, Nie M and Gu F:
Identification of five novel arginine vasopressin gene mutations in
patients with familial neurohypophyseal diabetes insipidus. Int J
Mol Med. 38:1243–1249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ye D, Dong F, Lu W, Zhang Z, Lu X, Li C
and Liu Y: A missense mutation in the arginine-vasopressin
neurophysin-II gene causes autosomal dominant neurohypophyseal
diabetes insipidus in a Chinese family. Clin Endocrinol (Oxf).
78:920–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo Y, Wang B, Qiu Y, Zhang C, Jin C, Zhao
Y, Zhu Q and Ma X: Clinical and molecular analysis of a Chinese
family with autosomal dominant neurohypophyseal diabetes insipidus
associated with a novel missense mutation in the
vasopressin-neurophysin II gene. Endocrine. 42:208–213. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baglioni S, Corona G, Maggi M, Serio M and
Peri A: Identification of a novel mutation in the arginine
vasopressin-neurophysin II gene affecting the sixth intrachain
disulfide bridge of the neurophysin II moiety. Eur J Endocrinol.
151:605–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arima H, Morishita Y, Hagiwara D, Hayashi
M and Oiso Y: Endoplasmic reticulum stress in vasopressin neurons
of familial diabetes insipidus model mice: Aggregate formation and
mRNA poly(A) tail shortening. Exp Physiol. 99:66–71. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahner A and Brodsky JL: Checkpoints in
ER-associated degradation: Excuse me, which way to the proteasome?
Trends Cell Biol. 14:474–478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gudinchet F, Brunelle F, Barth MO, Taviere
V, Brauner R, Rappaport R and Lallemand D: MR imaging of the
posterior hypophysis in children. AJR Am J Roentgenol. 153:351–354.
1989. View Article : Google Scholar : PubMed/NCBI
|
